Frontiers in Drug Discovery | Anti-inflammatory and Immunomodulating Agents

Case Report

Published on 04 Sep 2026

Case Report: Pembrolizumab–induced myasthenia gravis with isolated anti-titin antibody positivity after thymectomy for thymoma

in Anti-inflammatory and Immunomodulating Agents

Ju Hye Kim
Ji Yeon Chung
Jeong Bin Bong

Frontiers in Drug Discovery

doi 10.3389/fddsv.2026.1932554

719 views

Mini Review

Published on 02 Oct 2024

The role of the HIV-1 gut reservoir in driving early cardiovascular events in people living with HIV

in Anti-inflammatory and Immunomodulating Agents

Keri Kramer
Amanda Michael
Guadalupe Quiñones
Sebastian Roa
Susan P. Ribeiro
Cecile D. Lahiri
Christina Gavegnano

Frontiers in Drug Discovery

doi 10.3389/fddsv.2024.1334307

3,143 views

Original Research

Published on 13 Sep 2024

The chronicles of inflammation: uncovering of distinct patterns of NET degradation products

in Anti-inflammatory and Immunomodulating Agents

Janina Schoen
Marco Muñoz-Becerra
Jasmin Knopf
Favour Ndukwe
Moritz Leppkes
Dominik Roth
Anne Zeitler
Verena Gerlinde Frings
Bettina Hohberger
Victoria Zeisberg

Frontiers in Drug Discovery

doi 10.3389/fddsv.2024.1404103

3,712 views
2 citations

Mini Review

Published on 04 Mar 2024

A short review on CRP synthesis inhibition in cardiovascular disease

in Anti-inflammatory and Immunomodulating Agents

Myron Zaczkiewicz
Oliver Zimmermann
Jan Torzewski

Frontiers in Drug Discovery

doi 10.3389/fddsv.2024.1338535

6,993 views
7 citations

Editorial

Published on 22 Feb 2024

Editorial: Women in anti-inflammatory and immunomodulating agents: 2022

in Anti-inflammatory and Immunomodulating Agents

Jamie B. Spangler
Vanina A. Medina

Frontiers in Drug Discovery

doi 10.3389/fddsv.2024.1380166

2,040 views
1 citation

Original Research

Published on 18 Dec 2023

Global proteomics insights for a novel small compound targeting the non-integrin Laminin Receptor in a macrophage cell model

in Anti-inflammatory and Immunomodulating Agents

Abigail Haffner
Manoel Figueiredo Neto
C. Samuel Umbaugh
Tiago J. P. Sobreira
Timothy B. Lescun
Herman O. Sintim
Marxa L. Figueiredo

Frontiers in Drug Discovery

doi 10.3389/fddsv.2023.1326736

3,800 views
3 citations

Review

Published on 15 Dec 2023

Targeting mitochondrial metabolites and nucleic acids as an anti-inflammatory strategy

in Anti-inflammatory and Immunomodulating Agents

Yukun Min
Luke A. J. O’Neill

Frontiers in Drug Discovery

doi 10.3389/fddsv.2023.1294454

5,368 views
5 citations

Case Report

Published on 11 Dec 2023

Case report: C-reactive protein apheresis in cardiogenic shock: case series from the C-reactive protein apheresis in acute myocardial infarction-registry

in Anti-inflammatory and Immunomodulating Agents

J. Torzewski
S. Mattecka
W. Ries
C. D. Garlichs
F. Heigl
J. Fiedler
A. Sheriff

Frontiers in Drug Discovery

doi 10.3389/fddsv.2023.1286710

4,307 views
5 citations

Original Research

Published on 20 Jul 2023

9-PAHSA displays a weak anti-inflammatory potential mediated by specific antagonism of chemokine G protein-coupled receptors

in Anti-inflammatory and Immunomodulating Agents

Paulus Wohlfart
Mounir Chehtane
Ernesto Luna
Riyaz Mehta
Marcus Korn
Anish Konkar
Uwe Schwahn
Stefan Petry
Norbert Tennagels
Maximilian Bielohuby

Frontiers in Drug Discovery

doi 10.3389/fddsv.2023.1138461

5,666 views
2 citations

Mini Review

Published on 08 Dec 2022

Zingiber officinale (Ginger) as a treatment for inflammatory bowel disease: A review of current literature

in Anti-inflammatory and Immunomodulating Agents

Fatemeh Sadeghi Poor Ranjbar
Fatemeh Mohammadyari
Atharzahra Omidvar
Farhad Nikzad
Nooria Doozandeh Nargesi
Majid Varmazyar
Soroush Dehghankar
Fatemeh Vosoughian
Sepehr Olangian-Tehrani
Sepehr Nanbakhsh

Frontiers in Drug Discovery

doi 10.3389/fddsv.2022.1043617

16,990 views
9 citations

Systematic Review

Published on 25 Oct 2022

Characterization of KLH-driven immune responses in clinical studies: A systematic review

in Anti-inflammatory and Immunomodulating Agents

Mahdi Saghari
Manon A. A. Jansen
Hendrika W. Grievink
Robert Rissmann
Matthijs Moerland

Frontiers in Drug Discovery

doi 10.3389/fddsv.2022.992087

16,717 views
8 citations

Original Research

Published on 25 Oct 2022

Network pharmacology and molecular docking to explore Siraitia grosvenorii’s potential mechanism in preventing and treating proliferative diabetic retinopathy

in Anti-inflammatory and Immunomodulating Agents

Yehong Zhou
Fuxing Shu
Surendra Sarsaiya
Hu Jiang
Chengyan Jiang
Tingnian Qu
Ruixia Wang

Frontiers in Drug Discovery

doi 10.3389/fddsv.2022.1038224

4,313 views
3 citations

Review

Published on 21 Oct 2022

Nine receptors and binding proteins, four drugs, and one woman: Historical and personal perspectives

in Anti-inflammatory and Immunomodulating Agents

Daniela Novick

Frontiers in Drug Discovery

doi 10.3389/fddsv.2022.1001487

4,756 views
5 citations

13 articles

articles

Case Report: Pembrolizumab–induced myasthenia gravis with isolated anti-titin antibody positivity after thymectomy for thymoma

The role of the HIV-1 gut reservoir in driving early cardiovascular events in people living with HIV

The chronicles of inflammation: uncovering of distinct patterns of NET degradation products

A short review on CRP synthesis inhibition in cardiovascular disease

Editorial: Women in anti-inflammatory and immunomodulating agents: 2022

Global proteomics insights for a novel small compound targeting the non-integrin Laminin Receptor in a macrophage cell model

Targeting mitochondrial metabolites and nucleic acids as an anti-inflammatory strategy

Case report: C-reactive protein apheresis in cardiogenic shock: case series from the C-reactive protein apheresis in acute myocardial infarction-registry

9-PAHSA displays a weak anti-inflammatory potential mediated by specific antagonism of chemokine G protein-coupled receptors

Zingiber officinale (Ginger) as a treatment for inflammatory bowel disease: A review of current literature

Characterization of KLH-driven immune responses in clinical studies: A systematic review

Network pharmacology and molecular docking to explore Siraitia grosvenorii’s potential mechanism in preventing and treating proliferative diabetic retinopathy

Nine receptors and binding proteins, four drugs, and one woman: Historical and personal perspectives